T82.817S Embolism due to cardiac prosthetic devices, implants and grafts, sequela

Name of the Condition

• Embolism due to cardiac prosthetic devices, implants and grafts, sequela

Summary

Embolism due to cardiac prosthetic devices, implants, and grafts, sequela refers to the residual or chronic effects of an embolic event originating from these devices. This condition occurs after the acute phase of the embolism and may involve persistent symptoms, structural changes, or ongoing complications related to the blockage. The sequela can affect blood flow, tissue function, or device integrity, requiring long-term monitoring and management.

Causes

The sequela of embolism due to cardiac prosthetic devices, implants, or grafts typically results from unresolved or recurrent embolic events. These may stem from residual clot material, device-related inflammation, or mechanical issues that promote ongoing clot formation. Chronic changes in blood vessel structure or function, such as scarring or narrowing, can also contribute to persistent symptoms or complications.

Risk Factors

• History of embolism from cardiac prosthetic devices, implants, or grafts
• Chronic inflammation or infection around the implanted device
• Underlying hypercoagulable states or clotting disorders
• Prolonged immobility or reduced blood flow in the affected area
• Prior surgical interventions or device revisions

Symptoms

• Persistent pain, numbness, or weakness in the affected limb or organ
• Changes in skin color (pale, blue, or mottled) in the affected area
• Reduced or absent pulse in the affected region
• Shortness of breath or chest pain (if affecting the heart or lungs)
• Neurological deficits (e.g., confusion, weakness) if the brain is involved
• Fatigue or malaise unrelated to other causes

Diagnosis

Diagnosis involves evaluating the patient’s history of embolic events and current symptoms. Clinical assessment may include physical examination, imaging (e.g., ultrasound, CT, MRI) to assess tissue damage or device integrity, and laboratory tests to check for ongoing inflammation or clotting. Documentation should specify the nature of the sequela and its relationship to the prior embolic event.

Treatment Options

Treatment focuses on managing symptoms and preventing further complications. This may include anticoagulant or antiplatelet therapy to reduce clot risk, pain management, and physical therapy to improve function. In some cases, device revision or removal may be necessary. Long-term monitoring of device performance and vascular health is essential.

Prognosis and Follow-Up

Prognosis depends on the severity of the sequela and the patient’s overall health. Regular follow-up with a healthcare provider is critical to monitor for recurrent embolism, device failure, or worsening symptoms. Adjustments to treatment plans may be needed based on clinical progress or new complications.

Complications

• Recurrent embolism or thrombosis
• Chronic pain or disability
• Device malfunction or failure
• Infection or inflammation at the implant site
• Organ damage from prolonged reduced blood flow

Lifestyle & Prevention

• Adhere to prescribed medications (e.g., anticoagulants) as directed
• Maintain regular physical activity to support circulation
• Monitor for signs of infection or device issues
• Follow up with healthcare providers for routine evaluations
• Avoid activities that increase clot risk (e.g., prolonged immobility)

When to Seek Professional Help

Seek immediate medical attention if you experience sudden chest pain, shortness of breath, severe weakness, or neurological symptoms. Contact your healthcare provider for persistent pain, swelling, or changes in skin color in the affected area.

Tips for Medical Coders

Document the relationship between the sequela and the prior embolic event clearly. Include details about the type of cardiac prosthetic device, implants, or grafts involved, as well as the nature of the residual effects. Ensure the code T82.817S is used only when the condition is a sequela of the specified embolism.